• Eleftherios M Protopapas, Rito Mauro Lo ML 0000-0002-3175-3764 Department of Congenital Cardiac Surgery, 27288IRCCS Policlinico San Donato, San Donato Milanese, Italy., Vladimiro L Vida, George E Sarris, Christo I Tchervenkov, Bohdan J Maruszewski, Zdzislaw Tobota, Bistra Zheleva, Hao Zhang, Jeffery P Jacobs, Joseph A Dearani, Elizabeth H Stephens, James S Tweddell, Nestor F Sandoval, Emile A Bacha, Erle H Austin, Kisaburo Sakamoto, Sachin Talwar, Hiromi Kurosawa, Zohair Y Al Halees, Marcello B Jatene, Krishna S Iyer, Cheul Lee, Rajesh Sharma, Yasutaka Hirata, Frank Edwin, Jorge L Cervantes, James O'Brien, St Louis James J Division of Cardiac Surgery, 4204Children's Mercy Kansas City, MO, USA., James K Kirklin, and COVID-19 International Congenital Heart Surgery Taskforce.
• Athens Heart Surgery Institute, Athens, Greece.
• World J Pediatr Congenit Heart Surg. 2020 Nov 1; 11 (6): 689-696.

AbstractThe coronavirus disease 2019 (COVID-19) pandemic currently gripping the globe is impacting the entire health care system with rapidly escalating morbidities and mortality. Although the infectious risk to the pediatric population appears low, the effects on children with congenital heart disease (CHD) remain poorly understood. The closure of congenital heart surgery programs worldwide to address the growing number of infected individuals could have an unintended impact on future health for COVID-19-negative patients with CHD. Pediatric and congenital heart surgeons, given their small numbers and close relationships, are uniquely positioned to collectively assess the impact of the pandemic on surgical practice and care of children with CHD. We present the results of an international survey sent to pediatric and congenital heart surgeons characterizing the early impact of COVID-19 on the care of patients with CHD.

21 keywords...

hide…